Brawn Biotech Experiences Shift in Technical Indicators Amid Mixed Financial Fundamentals
Brawn Biotech has recently experienced a change in evaluation, influenced by its technical indicators. The stock's trend has shifted, showing a mix of bullish signals in various metrics, despite underlying challenges such as weak long-term fundamentals and declining net sales over the past five years.
Brawn Biotech, a microcap company in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in evaluation, reflecting changes in its technical indicators. The stock's technical trend has shifted from a sideways movement to a mildly bullish stance, indicating a potential change in market sentiment.Key technical metrics show a bullish outlook in the weekly MACD and a mildly bullish trend in the monthly Bollinger Bands. However, the KST presents a mixed picture with a bullish weekly reading contrasted by a bearish monthly signal. The daily moving averages also indicate bullish momentum, while the Dow Theory suggests no clear trend in both weekly and monthly assessments.
In terms of performance, Brawn Biotech's stock has shown a return of 7.99% over the past year, outperforming the broader market, which has seen negative returns. Despite this, the company faces challenges with weak long-term fundamentals, including a return on equity of 0% and declining net sales over the past five years.
Overall, the recent evaluation adjustment reflects a complex interplay of technical indicators and underlying financial metrics for Brawn Biotech.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
